Creative Biolabs-Immuno-oncology

Anti-CD22 (clone IRO28) SynExpress pU-G-I10-E CD8+ T Cells (CAT#: ITS-1124-CR11)

DatasheetDatasheet
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone IRO28). We employs the pX330 (pUC-GFP-IL-10-EcoRI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD22
Clone
IRO28
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
pUC
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
pX330
Transformation Accuracy
0.93
Cell Culture
Aseptic Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving